Showing results (431-440 of 538) with videos related to
Sort By:
Pageof 54
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomyDavid L Blum, Tatsuki Koyama, Amosy E M'Koma, et al.Digestion|May 27, 1999
Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humansP Michetti, G Dorta, P H Wiesel, et al.Clinical Breast Cancer|February 14, 2008
Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanesJoanne L Blum, Michael A Savin, Gerald Edelman, et al.Schweizerische Medizinische Wochenschrift|December 18, 1982
[Treatment of reflux esophagitis with ranitidine. A multicentric prospective study]H R Koelz, R Birchler, B Bron, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2014
Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II studyS Delaloge, R Wolp-Diniz, T Byrski, et al.Radiology|October 1, 1990
Usefulness of a short femur in the in utero detection of skeletal dysplasiasA B Kurtz, L Needleman, R J Wapner, et al.Future Oncology (London, England)|August 14, 2020
POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancerDebasish Tripathy, Joanne L Blum, Gabrielle B Rocque, et al.Gut|July 1, 1996
Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind studyJ Thorens, F Froehlich, W Schwizer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancerJ L Blum, S E Jones, A U Buzdar, et al.Clinical and Experimental Immunology|April 12, 2000
Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c miceE F Verdù, P Bercik, B Cukrowska, et al.Pageof 54